169 related articles for article (PubMed ID: 2454907)
21. Intrathecal anti-myelin basic protein antibody production in Chinese patients with multiple sclerosis.
Tsai YL; Wang CR; Chiu HC; Chuang CY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 Nov; 23(4):284-90. PubMed ID: 1713143
[TBL] [Abstract][Full Text] [Related]
22. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
[TBL] [Abstract][Full Text] [Related]
23. Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma.
Tsang PH; Tangnavarad K; Lesnick G; Perloff M; Holland JF; Bekesi JG
J Immunol Methods; 1980; 36(2):119-35. PubMed ID: 7000908
[TBL] [Abstract][Full Text] [Related]
24. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer.
Onji M
Gastroenterol Jpn; 1984 Aug; 19(4):328-35. PubMed ID: 6333369
[TBL] [Abstract][Full Text] [Related]
25. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
26. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of micro-leukocyte adherence inhibition as an immunodiagnostic test for pancreatic cancer.
Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Moore MC; Holyoke ED; Douglass HO
Cancer Res; 1979 Feb; 39(2 Pt 2):633-7. PubMed ID: 367589
[No Abstract] [Full Text] [Related]
28. [Enzyme-linked immunoadsorbent assays for myelin basic protein and antibodies to myelin basic protein in serum and CSF of patients with diseases of the nervous system].
Wang R; Chen J; Zhou S; Li C; Yuan G; Xu W; Wang X; Li J; Song Y; Gong N
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Jun; 26(2):131-4. PubMed ID: 7490015
[TBL] [Abstract][Full Text] [Related]
29. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.
O'Connor R; MacFarlane JK; Murray D; Thomson DM
Br J Cancer; 1978 Dec; 38(6):674-84. PubMed ID: 369586
[TBL] [Abstract][Full Text] [Related]
30. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI).
Tsang PH; Roboz JP; Holland JF; Bekesi JG
Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478
[TBL] [Abstract][Full Text] [Related]
31. Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients.
Fujisawa T; Waldman SR; Yonemoto RH
Cancer; 1977 Feb; 39(2):506-13. PubMed ID: 65207
[TBL] [Abstract][Full Text] [Related]
32. Humoral leukocyte adherence inhibition (H-LAI) before and after surgery in human breast cancer.
Horváth M; Tóth L; Tóth J; Fekete B
Neoplasma; 1985; 32(5):623-7. PubMed ID: 3906415
[TBL] [Abstract][Full Text] [Related]
33. Cell-mediated immunoreactivity of tumor-bearing mice with myelin basic protein and related peptides.
Klemm SA; Smith R; Halliday WJ
Cell Immunol; 1986 Jul; 100(2):434-42. PubMed ID: 2428511
[TBL] [Abstract][Full Text] [Related]
34. Cellular immunity to encephalitogenic peptide in tumour-bearing mice.
Yong WK; Halliday WJ
Br J Cancer; 1982 May; 45(5):754-61. PubMed ID: 6177329
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis.
Colombo E; Banki K; Tatum AH; Daucher J; Ferrante P; Murray RS; Phillips PE; Perl A
J Clin Invest; 1997 Mar; 99(6):1238-50. PubMed ID: 9077532
[TBL] [Abstract][Full Text] [Related]
36. Autoreactive T and B cells in nervous system diseases.
Sun JB
Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
[TBL] [Abstract][Full Text] [Related]
37. Microplate leucocyte adherence inhibition (LAI) assay in pancreatic cancer: detection of specific antitumor immunity with patients' peripheral blood cells and serum.
Goldrosen MH; Dasmahapatra K; Jenkins D; Howell JH; Arbuck SG; Moore MC; Douglass HO
Cancer; 1981 Mar; 47(6 Suppl):1614-9. PubMed ID: 6168355
[No Abstract] [Full Text] [Related]
38. Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.
Muraro PA; Vergelli M; Kalbus M; Banks DE; Nagle JW; Tranquill LR; Nepom GT; Biddison WE; McFarland HF; Martin R
J Clin Invest; 1997 Jul; 100(2):339-49. PubMed ID: 9218510
[TBL] [Abstract][Full Text] [Related]
39. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
Thomson DM
Cancer Res; 1979 Feb; 39(2 Pt 2):627-9. PubMed ID: 83917
[TBL] [Abstract][Full Text] [Related]
40. [Value of MS associated factors for test procedures in multiple sclerosis: 2. Angers' MS-induced substance in the LAI test].
Lehmitz R; Meyer U; Meyer-Rienecker HJ
Psychiatr Neurol Med Psychol (Leipz); 1983 Dec; 35(12):714-9. PubMed ID: 6366844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
